Biosimilar - PDFSEARCH.IO - Document Search Engine

Biosimilar
Results: 639

#	Item
381	Cosponsor H.R. 2725, The Lance/Eshoo FDA Safety Over Sequestration (FDA SOS) Act Last year, Congress passed the landmark Food and Drug Administration Safety and Innovation Act of[removed]FDASIA), which included a number of Add to Reading List Source URL: www.ihif.org Language: English - Date: 2013-07-31 12:45:12 Pharmaceuticals policy Food and Drug Administration Pharmaceutical industry Therapeutics Biosimilar Anna Eshoo Generic drug Food and Drug Administration Amendments Act Prescription Drug User Fee Act Pharmaceutical sciences Pharmacology Clinical research
382	Marketplace Policies, Practices, and Perspectives: 2008 Table of Contents 1. Introduction ...................................................... Add to Reading List Source URL: www.bms.com Language: English - Date: 2009-03-10 18:22:07 Pharmaceutical industry Pharmaceuticals policy Food and Drug Administration Biotechnology Biologic Pharmacy benefit management Biosimilar New Drug Application Biopharmaceutical Pharmaceutical sciences Pharmacology Health
383	Challenges for Non-Biological Complex Drugs (NBCDs) Prof. dr. Daan J.A. Crommelin Emeritus prof. Utrecht University, the Netherlands [removed] Add to Reading List Source URL: www.fda.gov Language: English Biosimilar Food and Drug Administration Biologic Bioequivalence Pharmaceutical industry Generic drug Pharmaceutical drug Abbreviated New Drug Application Pharmaceutical sciences Pharmacology Clinical research
384	BIO Principles on Patient Safety in the Substitution of Biologic Products Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are not chemically sy Add to Reading List Source URL: www.ihif.org Language: English - Date: 2013-01-23 11:12:11 Health Biosimilar Biologic Food and Drug Administration Generic drug Adverse effect Pharmacovigilance Pharmacology Pharmaceutical sciences Medicine
385	Subsequent entry biologics in Canada The case for multi-sector collaboration Roundtable Summary Report March[removed]Subsequent entry biologics in Canada\| 1 Add to Reading List Source URL: www.ppforum.ca Language: English - Date: 2014-04-11 07:09:16 Health Biosimilar Biologic Adverse effect Pharmacovigilance Pharmacology Medicine Pharmaceutical sciences
386	MAKINGDO INMAKINGDRUGS: INNOVATION POLICYAND PHARMACEUTICALMANUFACTURING Add to Reading List Source URL: bclawreview.org Language: English - Date: 2014-03-28 14:07:02 Health Pharmaceuticals policy Food and Drug Administration Generic drug Biosimilar NIPTE Test data exclusivity New Drug Application Compounding Pharmaceutical sciences Pharmacology Pharmaceutical industry
387	2014 FDA Justification of Estimates for Appropriations Committees Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Prescription Drug User Fee Act Office of Regulatory Affairs Priority review voucher Biosimilar Animal drugs Fee Food and Drug Administration Medicine Pharmacology
388	2014 FDA Justification of Estimates for Appropriations Committees Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Pharmaceuticals policy Food law Therapeutics United States Public Health Service Animal drugs Biosimilar Federal Food Drug and Cosmetic Act Medicine Pharmacology Health
389	2014 FDA Justification of Estimates for Appropriations Committees Add to Reading List Source URL: www.fda.gov Language: English Medicine Drugs Food and Drug Administration Food law Biosimilar Animal drugs Generic drug Abbreviated New Drug Application Fee Pharmacology Pharmaceutical sciences Pharmaceuticals policy
390	2014 FDA Justification of Estimates for Appropriations Committees Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Medical device Biosimilar Food Safety Modernization Act Criticism of the Food and Drug Administration Food Safety and Modernization Act Food and Drug Administration Medicine Health

UPDATE